Viewing Study NCT01705002


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-04-10 @ 12:40 PM
Study NCT ID: NCT01705002
Status: COMPLETED
Last Update Posted: 2018-07-10
First Post: 2012-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.
Sponsor: Lipomedix Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module